Q32 Bio (QTTB) Other Operating Expenses (2022)

Q32 Bio's (QTTB) quarterly Other Operating Expenses came in at $131.2 million in Q1 2022.

Q32 Bio (QTTB) Other Operating Expenses (2022) Analysis & Trends

Q32 Bio's Other Operating Expenses history runs 1 years deep, the most recent figure standing at $131.2 million for Q1 2022.

On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $131.2 million in Q1 2022; TTM through Dec 2022 was $131.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $11.7 million, changed N/A from the prior year.
Other Operating Expenses held at $131.2 million in Q1 2022 per QTTB's latest filing.
Across five years, Other Operating Expenses topped out at $131.2 million in Q1 2022 and bottomed at $131.2 million in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Q32 Bio	225.00 Mn	174.25 Mn	-

Download Data

Date	Value
Mar 31, 2022	131.25 Mn